US Patent Issued on Sept. 16 for "Tyrosine inhibitors with immunosuppressive activity in human neonatal keratinocyte progenitors" (California Inventor)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,414,978, issued on Sept. 16.

"Tyrosine inhibitors with immunosuppressive activity in human neonatal keratinocyte progenitors" was invented by Basil M. Hantash (Turlock, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Tyrosine inhibitors having immunosuppressive activity in human neonatal keratinocyte progenitors are described. Particular embodiments feature the immunosuppressive effects of a decapeptide and/or oxyresveratrol, as measured by two different methods: blockade of stimulated cell growth, and inhibition of cytotoxic killing."

The patent was filed on Jan. 20, 2020, under Application No. 17/420,396.

*For further information, including i...